Cargando…
Wip1 regulates the immunomodulatory effects of murine mesenchymal stem cells in type 1 diabetes mellitus via targeting IFN-α/BST2
Mesenchymal stem cells (MSCs) show significant therapeutic effects in type 1 diabetes mellitus (T1DM) as regulating the inflammatory processes. However, little is known about the detailed process of MSCs immunosuppression in T1DM. In this study, we investigated the effects of wild-type p53-induce ph...
Autores principales: | Zhou, Na, Liu, Weijiang, Zhang, Wei, Liu, Yuanlin, Li, Xue, Wang, Yang, Zheng, Rongxiu, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556269/ https://www.ncbi.nlm.nih.gov/pubmed/34716317 http://dx.doi.org/10.1038/s41420-021-00728-1 |
Ejemplares similares
-
Human umbilical cord mesenchymal stem cell-derived TGFBI attenuates streptozotocin-induced type 1 diabetes mellitus by inhibiting T-cell proliferation
por: Wu, Chushan, et al.
Publicado: (2023) -
Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells
por: Liu, Weijiang, et al.
Publicado: (2021) -
Characterization of a Maize Wip1 Promoter in Transgenic Plants
por: Zhang, Shengxue, et al.
Publicado: (2013) -
WIP1 and senescence: Oxygen matters
por: Olcina, Monica M, et al.
Publicado: (2014) -
PPM1D/WIP1 in medulloblastoma
por: Akamandisa, Mwangala P., et al.
Publicado: (2016)